TempraMed signs non-binding LOI for exclusive VIVI distribution in Cyprus

TempraMed signed a non-binding LOI with CPO Cyprus for exclusive distribution of VIVI Cap and VIVI Epi in Cyprus, subject to minimum annual purchase commitments and a combined volume increase of at least 20% year over year, with terms due to be finalized within 90 days from July 31, 2026.